Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies.

Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies.

Show other versions (1)

<h4>Background</h4>RTS,S/AS01 induced anti-circumsporozoite protein (CSP) IgG antibodies are associated with the vaccine efficacy. There is currently no international standardisation of the assays used in the measurement of anti-CSP IgG antibody concentrations for use in evaluations of t...

Full description

Bibliographic Details
Main Authors:	Robert M Mugo, Benedict Orindi, Faiz M Shee, Duncan Bellamy, Jedidah Mwacharo, Katie J Ewer, Philip Bejon, Francis M Ndungu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0286117

Similar Items

Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies
by: Robert M. Mugo, et al.
Published: (2023-01-01)

Correlations between three ELISA protocols measurements of RTS,S/AS01-induced anti-CSP IgG antibodies
by: Mugo, RM, et al.
Published: (2023)

Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children
by: Robert M. Mugo, et al.
Published: (2021-12-01)

Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children
by: Mugo, RM, et al.
Published: (2021)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children
by: Ndungu, F, et al.
Published: (2019)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
by: Ally Olotu, et al.
Published: (2011-01-01)

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E
by: Ndungu, F, et al.
Published: (2012)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
by: Bejon, P, et al.
Published: (2009)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.
by: Ally Olotu, et al.
Published: (2014-01-01)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children
by: Olotu, A, et al.
Published: (2014)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children [version 1; peer review: 1 approved, 2 approved with reservations]
by: Francis M. Ndungu, et al.
Published: (2019-03-01)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
by: Juliette Fortpied, et al.
Published: (2020-06-01)

Comparison of IgG-ELISA and IgG4-ELISA for Toxocara serodiagnosis
by: Noordin, R., et al.
Published: (2005)

RTS,S/AS01 vaccine (Mosquirix™): an overview
by: Matthew B. Laurens
Published: (2020-03-01)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
by: Olotu, A, et al.
Published: (2011)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
by: Olotu, A, et al.
Published: (2016)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
by: Olotu, A, et al.
Published: (2010)

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
by: Olotu, A, et al.
Published: (2013)

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
by: Nyagwange, J, et al.
Published: (2021)

Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis
by: Sidhartha Chaudhury, et al.
Published: (2017-08-01)

RTS,S/AS01 malaria vaccine in African children.
by: Hill, A
Published: (2012)

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
by: Bejon, P, et al.
Published: (2011)

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01E
by: M. Sanni Ali, et al.
Published: (2025-02-01)

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
by: Mark E Polhemus, et al.
Published: (2009-07-01)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
by: Aroosa Younis Nadeem, et al.
Published: (2022-04-01)

THE RTS,S MALARIA VACCINE What is the efficacy of the RTS,S malaria vaccine?
by: Duncan, C, et al.
Published: (2011)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
by: Bejon, P, et al.
Published: (2008)

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
by: Gosling, R, et al.
Published: (2015)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
by: Roly Gosling, et al.
Published: (2016-04-01)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.
by: Lievens, M, et al.
Published: (2011)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
by: Daniel Ansong, et al.
Published: (2011-04-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
by: John N Waitumbi, et al.
Published: (2009-11-01)

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01 E
by: Ali, MS, et al.
Published: (2025)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
by: Corinne S. Merle, et al.
Published: (2023-08-01)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
by: Hassan Mumtaz, et al.
Published: (2023-06-01)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
by: Griffin J. Bell, et al.
Published: (2020-06-01)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
by: Agnandji, S, et al.
Published: (2012)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
by: Seth Owusu-Agyei, et al.
Published: (2010-01-01)

Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa
by: Galactionova, K, et al.
Published: (2017)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS,S/AS01 malaria vaccine in African children
by: Lievens Marc, et al.
Published: (2011-08-01)